Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease
BACKGROUND AND AIMS:The advent of direct-acting antiviral agents promises to change the management of hepatitis C virus infection (HCV) in patients with chronic kidney disease (CKD), a patient group in which the treatment of hepatitis C was historically challenging. We investigated the safety and ef...
Published in: | Nefrología |
---|---|
Main Authors: | , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Sociedad Española de Nefrología Dr Rafael Matesanz
|
Subjects: | |
Online Access: | http://hdl.handle.net/11336/123087 |